1. |
Global Initiative for Asthma. Global strategy for asthma management and prevention, 2018. Available from: www.ginasthma.org.
|
2. |
Wandee J, Prawan A, Senggunprai L, et al. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway. Life Sci, 2018, 207(8): 172-183.
|
3. |
Kianmeher M, Ghorani V, Boskabady MH. Animal models of asthma: utility and limitations. J Asthma Allergy, 2017, 10(11): 293-301.
|
4. |
Rubini A, Catena V, Del Monte D, et al. The effects of nifedipine on respiratory mechanics investigated by theend-inflation occlusion method in the rat. J Enzyme Inhib Med Chem, 2017, 32(1): 1-4.
|
5. |
Cho JY, Miller M, Baek KJ, et al. Role of estrogen receptors α and β in a murine model of asthma: exacerbated airway hyperresponsiveness and remodeling in ERβ knockout mice. Front Pharmacol, 2020, 10(2): 1499-1514.
|
6. |
Sherkawy MM, Abo-Youssef AM, Salama AAA, et al. Fluoxetine protects against OVA induced bronchial asthma and depression in rats. Eur J Pharmacol, 2018, 837(10): 25-32.
|
7. |
Liang X, Wang JJ, Chen WW, et al. Inhibition of airway remodeling and inflammation by isoforskolin in PDGF-induced rat ASMCs and OVA-induced rat asthma model. Biomed Pharmacother, 2017, 95(11): 275-286.
|
8. |
Boulet LP. Airway remodeling in asthma: update on mechanisms and therapeutic approaches. Curr Opin Pulm Med, 2018, 24(1): 56-62.
|
9. |
Kaczmarek KA, Clifford RL, Knox AJ. Epigenetic changes in airway smooth muscle as a driver of airway inflammation and remodeling in asthma. Chest, 2019, 155(4): 816-824.
|
10. |
Calixto MC, Lintomen L, André DM, et al. Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. PLoS One, 2013, 8(10): e76786.
|
11. |
Park CS, Bang B, Kwon H, et al. Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochem Pharmacol, 2012, 84(12): 1660-1670.
|
12. |
Hadad SM, Hardie DG, Appleyard V, et al. Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle. Clin Transl Oncol, 2014, 16(8): 746-752.
|
13. |
Shimazu K, Tada Y, Morinaga T, et al. Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways. BMC Cancer, 2017, 17(1): 309-323.
|
14. |
Daskalopoulos EP, Dufeys C, Bertrand L, et al. AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation. J Mol Cell Cardiol, 2016, 91(2): 188-200.
|
15. |
Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res, 2005, 65(10): 3980-3985.
|
16. |
Barr AR, Heldt FS, Zhang TL, et al. A dynamical framework for the all-or-none G1/S transition. Cell Syst, 2016, 2(1): 27-37.
|
17. |
Kreis NN, Louwen F, Yuan J. Less understood issues: p21Cip1 in mitosis and its therapeutic potential. Oncogene, 2015, 34(14): 1758-1767.
|